<div id="readability-page-1"><article>REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will present at the Guggenheim Emerging Outlook: Biotech Summit 2026 being held from February 11-12, 2026 in New York.Details of the event are as follows: Date: Thursday, February 12, 2026 Time: 2:00p.m. ETThe live audio webcast can be accessed on the Investors section of Adicet Bio’s website at http://www.adicetbio.com. An archived replay will be available for 30 days following the presentation.About Adicet Bio, Inc.Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. For more information, please visit our website at https://www.adicetbio.com.<img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAxMzA5Nzk2MzFyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAxMzA5Nzk2MzFyMQ"/>View source version on businesswire.com: https://www.businesswire.com/news/home/20260130979631/en/Adicet Bio., Inc. Investor and Media ContactsAnne Bowdidge abowdidge@adicetbio.comPenelope Belnap Precision AQ penelope.belnap@precisionaq.comSource: Adicet Bio, Inc.</article></div>

ACET

SBIO

IBBQ

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company, announced that CEO Chen Schor will present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026, at 2:00 p.m. ET in New York. The presentation will be accessible via a live audio webcast on the company's website, with an archived replay available for 30 days.

StockTitan

VanEck Biotech ETF

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

First Trust NYSE Arca Biotech Index Fd

Adicet Bio

ALPS Medical Breakthrough

Invesco Nasdaq Biotechnology ETF

iShares Biotechnology ETF

Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 | ACET Stock News